DK0917466T3 - Oralt antikonceptionsmiddel - Google Patents

Oralt antikonceptionsmiddel

Info

Publication number: DK0917466T3
Authority: DK; Denmark
Prior art keywords: combination; daily dosage; phase; administered; days
Prior art date: 1996-07-26

Application number

DK97935047T

Other languages

English (en)

Inventor

Michael Jay Gast

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-07-26

Filing date

1997-07-23

Publication date

2004-12-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24757747&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0917466(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-07-23 Application filed by Wyeth Corp filed Critical Wyeth Corp

2004-12-20 Application granted granted Critical

2004-12-20 Publication of DK0917466T3 publication Critical patent/DK0917466T3/da

Links

229940127234 oral contraceptive Drugs 0.000 title 1
239000003539 oral contraceptive agent Substances 0.000 title 1
RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical class C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 abstract 6
239000000262 estrogen Substances 0.000 abstract 6
229940011871 estrogen Drugs 0.000 abstract 6
239000000583 progesterone congener Substances 0.000 abstract 6
BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 abstract 3
BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 abstract 3
AZFLJNIPTRTECV-FUMNGEBKSA-N dienogest Chemical compound C1CC(=O)C=C2CC[C@@H]([C@H]3[C@@](C)([C@](CC3)(O)CC#N)CC3)C3=C21 AZFLJNIPTRTECV-FUMNGEBKSA-N 0.000 abstract 3
229960003309 dienogest Drugs 0.000 abstract 3
METQSPRSQINEEU-UHFFFAOYSA-N dihydrospirorenone Natural products CC12CCC(C3(CCC(=O)C=C3C3CC33)C)C3C1C1CC1C21CCC(=O)O1 METQSPRSQINEEU-UHFFFAOYSA-N 0.000 abstract 3
METQSPRSQINEEU-HXCATZOESA-N drospirenone Chemical compound C([C@]12[C@H]3C[C@H]3[C@H]3[C@H]4[C@@H]([C@]5(CCC(=O)C=C5[C@@H]5C[C@@H]54)C)CC[C@@]31C)CC(=O)O2 METQSPRSQINEEU-HXCATZOESA-N 0.000 abstract 3
229960004845 drospirenone Drugs 0.000 abstract 3
230000001076 estrogenic effect Effects 0.000 abstract 3
229960002568 ethinylestradiol Drugs 0.000 abstract 3
JUNDJWOLDSCTFK-MTZCLOFQSA-N trimegestone Chemical compound C1CC2=CC(=O)CCC2=C2[C@@H]1[C@@H]1CC[C@@](C(=O)[C@@H](O)C)(C)[C@@]1(C)CC2 JUNDJWOLDSCTFK-MTZCLOFQSA-N 0.000 abstract 3
229950008546 trimegestone Drugs 0.000 abstract 3
230000027758 ovulation cycle Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Gynecology & Obstetrics (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DK97935047T 1996-07-26 1997-07-23 Oralt antikonceptionsmiddel DK0917466T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US68678696A	1996-07-26	1996-07-26
EP97935047A EP0917466B1 (en)	1996-07-26	1997-07-23	Oral contraceptive

Publications (1)

Publication Number	Publication Date
DK0917466T3 true DK0917466T3 (da)	2004-12-20

Family

ID=24757747

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97935047T DK0917466T3 (da)	1996-07-26	1997-07-23	Oralt antikonceptionsmiddel

Country Status (17)

Country	Link
EP (1)	EP0917466B1 (da)
JP (1)	JP2000515888A (da)
KR (1)	KR100501021B1 (da)
CN (1)	CN1119999C (da)
AT (1)	ATE278406T1 (da)
AU (1)	AU713016B2 (da)
BR (1)	BR9710565A (da)
CA (1)	CA2261687A1 (da)
DE (1)	DE69731092T2 (da)
DK (1)	DK0917466T3 (da)
ES (1)	ES2229378T3 (da)
HU (1)	HUP9904345A3 (da)
IL (1)	IL127923A (da)
NZ (1)	NZ333862A (da)
PT (1)	PT917466E (da)
SI (1)	SI0917466T1 (da)
WO (1)	WO1998004268A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4344462C2 (de)	1993-12-22	1996-02-01	Schering Ag	Zusammensetzung für die Empfängnisverhütung
FR2754179B1 (fr)	1996-10-08	1998-12-24	Theramex	Nouvelle composition hormononale et son utilisation
DK1380301T3 (da) *	1999-08-31	2009-04-20	Bayer Schering Pharma Ag	Farmaceutisk sammensætning af ethinylestradiol og drospirenon til anvendelse som svangerskabsforebyggende middel
FR2801218B1 (fr) *	1999-11-23	2001-12-28	Hoechst Marion Roussel Inc	Compositions pharmaceutiques comprenant de la trimegestone, leurs procedes de preparation ainsi que le conditionnement primaire les renfermant
US7297688B2 (en)	2000-06-08	2007-11-20	Wyeth	Starter kit for low dose oral contraceptives
NZ591627A (en) *	2001-12-05	2012-09-28	Teva Womens Health Inc	Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
EP1735056B1 (en)	2004-03-19	2012-10-24	Warner Chilcott Company, LLC	Extended cycle multiphasic oral contraceptive method
DE102004019743B4 (de)	2004-04-20	2008-11-27	Bayer Schering Pharma Aktiengesellschaft	Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
US8022053B2 (en) *	2004-11-02	2011-09-20	Bayer Schering Pharma Aktiengesellschaft	Oral solid dosage forms containing a low dose of estradiol
US7704984B2 (en) *	2005-04-22	2010-04-27	Warner Chilcott Company, Llc	Extended estrogen dosing contraceptive regimen
DE102005034498A1 (de) *	2005-07-20	2007-01-25	Grünenthal GmbH	Orale Kontrazeption mit Trimegeston
US8153616B2 (en)	2005-10-17	2012-04-10	Bayer Pharma Aktiengesellschaft	Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
MX2008011074A (es)	2006-03-02	2008-09-10	Warner Chilcott Co Inc	Metodo anticonceptivo oral multifasico de ciclo prolongado.
EP1930010A1 (de)	2006-10-20	2008-06-11	Bayer Schering Pharma Aktiengesellschaft	Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2365103C3 (de) *	1973-12-21	1980-08-28	Schering Ag, 1000 Berlin Und 4619 Bergkamen	V erwendung von Hormonen zur Kontrazeption
US4616006A (en) *	1983-09-26	1986-10-07	Ortho Pharmaceutical Corporation	Triphasic oral contraceptive
US4628051A (en) *	1983-09-26	1986-12-09	Ortho Pharmaceutical Corporation	Triphasic oral contraceptive
FI101601B (fi) *	1987-09-24	1998-07-31	Jencap Res Ltd	Ehkäisyvalmiste sekä estrogeenin ja progestiinin käyttö ehkäisyvalmist een valmistusmenetelmässä
IE71203B1 (en) *	1990-12-13	1997-02-12	Akzo Nv	Low estrogen oral contraceptives
IE62665B1 (en) *	1990-12-17	1995-02-22	Akzo Nv	Contraceptive regimen
DE4313926A1 (de) *	1993-04-28	1994-11-03	Jenapharm Gmbh	Pharmazeutisches Mehrphasenpräparat zur hormonalen Kontrazeption
NL9301562A (nl) *	1993-09-09	1995-04-03	Saturnus Ag	Preparaat voor substitutietherapie.
DE4344462C2 (de) *	1993-12-22	1996-02-01	Schering Ag	Zusammensetzung für die Empfängnisverhütung
DE4411585A1 (de) *	1994-03-30	1995-10-05	Schering Ag	Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE4429374C1 (de) *	1994-08-12	1996-02-01	Jenapharm Gmbh	Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente

1997
- 1997-07-23 AU AU38076/97A patent/AU713016B2/en not_active Ceased
- 1997-07-23 AT AT97935047T patent/ATE278406T1/de not_active IP Right Cessation
- 1997-07-23 NZ NZ333862A patent/NZ333862A/xx unknown
- 1997-07-23 EP EP97935047A patent/EP0917466B1/en not_active Revoked
- 1997-07-23 DE DE69731092T patent/DE69731092T2/de not_active Expired - Fee Related
- 1997-07-23 DK DK97935047T patent/DK0917466T3/da active
- 1997-07-23 KR KR10-1999-7000594A patent/KR100501021B1/ko not_active Expired - Fee Related
- 1997-07-23 PT PT97935047T patent/PT917466E/pt unknown
- 1997-07-23 IL IL12792397A patent/IL127923A/en not_active IP Right Cessation
- 1997-07-23 JP JP10508919A patent/JP2000515888A/ja not_active Ceased
- 1997-07-23 BR BR9710565A patent/BR9710565A/pt not_active Application Discontinuation
- 1997-07-23 ES ES97935047T patent/ES2229378T3/es not_active Expired - Lifetime
- 1997-07-23 WO PCT/US1997/012786 patent/WO1998004268A1/en not_active Ceased
- 1997-07-23 CA CA002261687A patent/CA2261687A1/en not_active Abandoned
- 1997-07-23 SI SI9730679T patent/SI0917466T1/xx unknown
- 1997-07-23 HU HU9904345A patent/HUP9904345A3/hu unknown
- 1997-07-23 CN CN97198093A patent/CN1119999C/zh not_active Expired - Fee Related

Also Published As

Publication number	Publication date
IL127923A (en)	2004-07-25
NZ333862A (en)	2000-08-25
AU3807697A (en)	1998-02-20
PT917466E (pt)	2004-12-31
BR9710565A (pt)	1999-08-17
CN1230888A (zh)	1999-10-06
SI0917466T1 (en)	2005-02-28
ES2229378T3 (es)	2005-04-16
CN1119999C (zh)	2003-09-03
JP2000515888A (ja)	2000-11-28
DE69731092D1 (de)	2004-11-11
CA2261687A1 (en)	1998-02-05
IL127923A0 (en)	1999-11-30
HUP9904345A3 (en)	2000-11-28
AU713016B2 (en)	1999-11-18
EP0917466B1 (en)	2004-10-06
ATE278406T1 (de)	2004-10-15
KR20000029537A (ko)	2000-05-25
EP0917466A1 (en)	1999-05-26
DE69731092T2 (de)	2005-02-10
HUP9904345A2 (hu)	2000-06-28
WO1998004268A1 (en)	1998-02-05
KR100501021B1 (ko)	2005-07-18

Publication	Publication Date	Title
DE69729956D1 (de)	2004-08-26	Orale einstufige empfängnisverhütungsmethode und kombinationspräparat das gestagen und estrogen enthält
AU645637B2 (en)	1994-01-20	Contraceptive regimen
CY1105276T1 (el)	2010-03-03	Τριφασικο στοματικο αντισυλληπτικο
HK67393A (en)	1993-07-23	Combination dosage form for pre-menopausal women
WO1998004246A3 (en)	2002-09-26	Triphasic contraceptive method and kit comprising a combination of a progestin and estrogen
PT917466E (pt)	2004-12-31	Contraceptivo oral
AU4043597A (en)	1998-02-20	Biphasic contraceptive method and kit comprising a combination of a progestin and estrogen